Admedus would be a good investment if the fundamental strategy looked like being viable, however ...
Strategy to date has been to develop, produce & market their suite of surgical products.
The first, and even in combination with the 2nd, doesn't equal viable.
So who cares what they've developed? Who cares what volume they can produce? On what basis can we anticipate a meaningful slice of their target market will buy the product?
Unless of course Admedus changes tack, and sells their invention to a player in the medical-surgical space who can sell the product.
But nothing I've seen yet suggests any such change in tack is contemplated.
I'm sitting on a few AHZO oppies. Bottom drawer.
Regards,
P
- Forums
- ASX - By Stock
- AVR
- Ann: Promising Interim Results from TAVR Animal Study
Ann: Promising Interim Results from TAVR Animal Study, page-42
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$12.25 |
Change
0.350(2.94%) |
Mkt cap ! $251.5M |
Open | High | Low | Value | Volume |
$12.00 | $12.25 | $12.00 | $104.1K | 8.618K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 105 | $12.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.30 | 64 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1440 | 12.100 |
1 | 985 | 12.010 |
2 | 3634 | 12.000 |
1 | 152 | 11.990 |
1 | 45 | 11.980 |
Price($) | Vol. | No. |
---|---|---|
12.200 | 500 | 1 |
12.250 | 582 | 1 |
12.370 | 615 | 1 |
12.380 | 150 | 1 |
12.400 | 500 | 1 |
Last trade - 10.13am 11/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |